Issue 1/2023
Content (10 Articles)
Novel Pulmonary Delivery of Drugs for the Management of Atrial Fibrillation
Nazrul Islam, Emma Cichero, Shafiqur Rahman, Isuru Ranasinghe
Challenges and Possible Solutions to Direct-Acting Oral Anticoagulants (DOACs) Dosing in Patients with Extreme Bodyweight and Renal Impairment
Ezekwesiri Michael Nwanosike, Wendy Sunter, Hamid A. Merchant, Barbara R. Conway, Muhammad Ayub Ansari, Syed Shahzad Hasan
Adherence and Discontinuation of Disease-Specific Therapies for Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
Sami Qadus, Abdallah Y. Naser, Richard Ofori-Asenso, Zanfina Ademi, Safaa Al Awawdeh, Danny Liew
Very Short Versus Longer Dual Antiplatelet Treatment After Coronary Interventions: A Systematic Review and Meta-analysis
Grigorios Tsigkas, Anastasios Apostolos, Aikaterini Trigka, Dimitrios Chlorogiannis, Konstantinos Katsanos, Konstantinos Toutouzas, Dimitrios Alexopoulos, Emmanouil S. Brilakis, Periklis Davlouros
Cost-Effectiveness of Adding Empagliflozin to Standard Treatment for Heart Failure with Preserved Ejection Fraction Patients in China
Yake Lou, Tianyang Hu, Jing Huang
A Real-World Matched Cohort Study of the Effect of Concomitant Amiodarone or Diltiazem Administration on Apixaban Peak and Trough Concentrations
David A. Bookstaver, Michael Ainsworth, Melinda Gleaton, Erin Milner
Potential Cardiovascular Events Avoided with Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared with Ezetimibe Alone in Patients with Atherosclerotic Cardiovascular Disease Taking Maximally Tolerated Statins
R. Brett McQueen, Seth J. Baum, Michael J. Louie, William J. Sasiela, Aikaterini Bilitou, Hemal Shah, Beth Nash, Kristin K. Gillard, Kausik K. Ray
Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry
Michele Millesimo, Edoardo Elia, Giorgio Marengo, Ovidio De Filippo, Sergio Raposeiras-Roubin, Wojciech Wańha, Emad Abu-Assi, Tim Kinnaird, Albert Ariza-Solé, Christoph Liebetrau, Sergio Manzano-Fernández, Mario Iannaccone, Jose Paulo Simao Henriques, Christian Templin, Stephen B. Wilton, Lazar Velicki, Ioanna Xanthopoulou, Luis Correia, Enrico Cerrato, Andrea Rognoni, Iván Nuñez-Gil, Xiantao Song, Tetsuma Kawaji, Giorgio Quadri, Zenon Huczek, Rafael Cobas Paz, José Ramón González Juanatey, Shao-Ping Nie, Masa-aki Kawashiri, Alberto Dominguez-Rodriguez, Federico Conrotto, Fabrizio D’Ascenzo, Gaetano Maria De Ferrari
Statins Reduce Bleeding Risk in Patients Taking Oral Anticoagulants for Nonvalvular Atrial Fibrillation: A Retrospective Registry Study
Kazutaka Uchida, Shinichiro Ueda, Fumihiro Sakakibara, Norito Kinjo, Mari Nezu, Hideki Arai, Takeshi Morimoto
Safety and Tolerability of Tecarfarin (ATI-5923) in Healthy Chinese Volunteers: Multiple Oral Dose-Escalation Phase I Trial
Qiang Zhou, Zhiqiang Wang, Heming Wang, Zhidong Chen, Xiaoyi Li, Xiangrong Dai, Yong Zhang, Xiaohui Yu, Renpeng Zhou, Wei Hu